349 related articles for article (PubMed ID: 34867935)
1. Epstein-Barr Virus and the Origin of Myalgic Encephalomyelitis or Chronic Fatigue Syndrome.
Ruiz-Pablos M; Paiva B; Montero-Mateo R; Garcia N; Zabaleta A
Front Immunol; 2021; 12():656797. PubMed ID: 34867935
[TBL] [Abstract][Full Text] [Related]
2. Cytomegalovirus, Epstein-Barr virus, and human herpesvirus-6 infections in patients with myalgic еncephalomyelitis/chronic fatigue syndrome.
Shikova E; Reshkova V; Kumanova А; Raleva S; Alexandrova D; Capo N; Murovska M; On Behalf Of The European Network On Me/Cfs Euromene
J Med Virol; 2020 Dec; 92(12):3682-3688. PubMed ID: 32129496
[TBL] [Abstract][Full Text] [Related]
3. Early Growth Response Gene Upregulation in Epstein-Barr Virus (EBV)-Associated Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS).
Kerr J
Biomolecules; 2020 Oct; 10(11):. PubMed ID: 33114612
[TBL] [Abstract][Full Text] [Related]
4. Epstein-Barr Virus dUTPase Induces Neuroinflammatory Mediators: Implications for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome.
Williams PhD MV; Cox B; Lafuse PhD WP; Ariza ME
Clin Ther; 2019 May; 41(5):848-863. PubMed ID: 31040055
[TBL] [Abstract][Full Text] [Related]
5. Cellular Immune Function in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS).
Cliff JM; King EC; Lee JS; Sepúlveda N; Wolf AS; Kingdon C; Bowman E; Dockrell HM; Nacul L; Lacerda E; Riley EM
Front Immunol; 2019; 10():796. PubMed ID: 31057538
[TBL] [Abstract][Full Text] [Related]
6. Antibodies to Human Herpesviruses in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Patients.
Blomberg J; Rizwan M; Böhlin-Wiener A; Elfaitouri A; Julin P; Zachrisson O; Rosén A; Gottfries CG
Front Immunol; 2019; 10():1946. PubMed ID: 31475007
[TBL] [Abstract][Full Text] [Related]
7. Epstein-Barr virus-acquired immunodeficiency in myalgic encephalomyelitis-Is it present in long COVID?
Ruiz-Pablos M; Paiva B; Zabaleta A
J Transl Med; 2023 Sep; 21(1):633. PubMed ID: 37718435
[TBL] [Abstract][Full Text] [Related]
8. Serological profiling of the EBV immune response in Chronic Fatigue Syndrome using a peptide microarray.
Loebel M; Eckey M; Sotzny F; Hahn E; Bauer S; Grabowski P; Zerweck J; Holenya P; Hanitsch LG; Wittke K; Borchmann P; Rüffer JU; Hiepe F; Ruprecht K; Behrends U; Meindl C; Volk HD; Reimer U; Scheibenbogen C
PLoS One; 2017; 12(6):e0179124. PubMed ID: 28604802
[TBL] [Abstract][Full Text] [Related]
9. Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: The Human Herpesviruses Are Back!
Ariza ME
Biomolecules; 2021 Jan; 11(2):. PubMed ID: 33572802
[TBL] [Abstract][Full Text] [Related]
10. IgG Antibody Responses to Epstein-Barr Virus in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: Their Effective Potential for Disease Diagnosis and Pathological Antigenic Mimicry.
Fonseca A; Szysz M; Ly HT; Cordeiro C; Sepúlveda N
Medicina (Kaunas); 2024 Jan; 60(1):. PubMed ID: 38256421
[No Abstract] [Full Text] [Related]
11. EBV/HHV-6A dUTPases contribute to myalgic encephalomyelitis/chronic fatigue syndrome pathophysiology by enhancing TFH cell differentiation and extrafollicular activities.
Cox BS; Alharshawi K; Mena-Palomo I; Lafuse WP; Ariza ME
JCI Insight; 2022 Jun; 7(11):. PubMed ID: 35482424
[TBL] [Abstract][Full Text] [Related]
12. The spread of EBV to ectopic lymphoid aggregates may be the final common pathway in the pathogenesis of ME/CFS.
Eriksen W
Med Hypotheses; 2017 May; 102():8-15. PubMed ID: 28478837
[TBL] [Abstract][Full Text] [Related]
13. Myalgic Encephalomyelitis/Chronic Fatigue Syndrome as a Hyper-Regulated Immune System Driven by an Interplay Between Regulatory T Cells and Chronic Human Herpesvirus Infections.
Sepúlveda N; Carneiro J; Lacerda E; Nacul L
Front Immunol; 2019; 10():2684. PubMed ID: 31824487
[TBL] [Abstract][Full Text] [Related]
14. IgM serum antibodies to Epstein-Barr virus are uniquely present in a subset of patients with the chronic fatigue syndrome.
Lerner AM; Beqaj SH; Deeter RG; Fitzgerald JT
In Vivo; 2004; 18(2):101-6. PubMed ID: 15113035
[TBL] [Abstract][Full Text] [Related]
15. Deficient EBV-specific B- and T-cell response in patients with chronic fatigue syndrome.
Loebel M; Strohschein K; Giannini C; Koelsch U; Bauer S; Doebis C; Thomas S; Unterwalder N; von Baehr V; Reinke P; Knops M; Hanitsch LG; Meisel C; Volk HD; Scheibenbogen C
PLoS One; 2014; 9(1):e85387. PubMed ID: 24454857
[TBL] [Abstract][Full Text] [Related]
16. Epigenetic reprograming in myalgic encephalomyelitis/chronic fatigue syndrome: A narrative of latent viruses.
Apostolou E; Rosén A
J Intern Med; 2024 Jul; 296(1):93-115. PubMed ID: 38693641
[TBL] [Abstract][Full Text] [Related]
17. Epstein-Barr Virus Induced Gene-2 Upregulation Identifies a Particular Subtype of Chronic Fatigue Syndrome/Myalgic Encephalomyelitis.
Kerr JR
Front Pediatr; 2019; 7():59. PubMed ID: 30918887
[TBL] [Abstract][Full Text] [Related]
18. Increased expression of activation antigens on CD8+ T lymphocytes in Myalgic Encephalomyelitis/chronic fatigue syndrome: inverse associations with lowered CD19+ expression and CD4+/CD8+ ratio, but no associations with (auto)immune, leaky gut, oxidative and nitrosative stress biomarkers.
Maes M; Bosmans E; Kubera M
Neuro Endocrinol Lett; 2015; 36(5):439-46. PubMed ID: 26707044
[TBL] [Abstract][Full Text] [Related]
19. Human Leukocyte Antigen alleles associated with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS).
Lande A; Fluge Ø; Strand EB; Flåm ST; Sosa DD; Mella O; Egeland T; Saugstad OD; Lie BA; Viken MK
Sci Rep; 2020 Mar; 10(1):5267. PubMed ID: 32210306
[TBL] [Abstract][Full Text] [Related]
20. Studies on the relationship between chronic fatigue syndrome and Epstein-Barr virus in Japan.
Kawai K; Kawai A
Intern Med; 1992 Mar; 31(3):313-8. PubMed ID: 1319246
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
